Foghorn Therapeutics Logo

Foghorn Therapeutics

Director, DMPK

Posted 2 Days Ago
Be an Early Applicant
In-Office
Watertown, MA
200K-240K Annually
Senior level
In-Office
Watertown, MA
200K-240K Annually
Senior level
The Director, DMPK oversees ADME/PK studies, collaborates with teams, interprets data, contributes to candidate selection and ensures regulatory compliance in drug development.
The summary above was generated by AI

Our Culture: Why work with us?

At Foghorn Therapeutics, we believe in “People First, Mission Always.”

We put “People First” because we know our people are the key to everything we will accomplish. We value the diversity of background, ideas, perspectives and experiences that our team members bring to Foghorn Therapeutics – demonstrated by our community speaking more than 22 languages and representing over 24 nationalities. We value our teammates as people, not just as employees – validated by our actions that let our people know that we care about them, their families, and their lives.

We say “Mission Always” because we know a relentless commitment to our mission will make a difference in the lives of others. We believe our success will come from evaluating the data to follow the science. We work hard to develop a new class of therapies that could improve the lives of over 2.5 million people with cancer.

Our culture is focused on succeeding through the evaluation of data, not people. And in that, relationships can flourish and develop.

Our Science:

The groundbreaking science behind our therapies continues to yield vital insights into diseases that have confounded physicians and researchers. Our core scientific approach is centered on the chromatin regulatory system, which opens and closes the right sections of DNA at the right time. Breakdowns in the chromatin regulatory system lead to a wide range of diseases, including cancer, impacting millions of people.

Our proprietary Gene Traffic Control® platform is a powerful tool for understanding and modulating the chromatin regulatory system. We are pursuing multiple treatments for breakdowns in this system. We are the only company with the ability to study and target the chromatin regulatory system at scale, in context, and in an integrated way.

The Role:

This position offers an exciting opportunity to be a key part of a research and development organization that is pioneering a new class of medicines. The Director, DMPK project representative, will provide direct support to multiple project teams across the discovery and early clinical development portfolio.

What you will be doing:

  • Design and execute issue-driven ADME/PK studies to address critical discovery project needs, supporting program progression through lead optimization to early development
  • Analyze and interpret preclinical ADME/PK data, communicating results and recommendations to project teams effectively
  • Build and maintain strong collaborations with internal and external partners across chemistry, biology, pharmacology, CMC and other R&D disciplines
  • Partner with discovery and clinical groups to design preclinical studies that inform clinical dosing strategy
  • Contribute to key decisions including candidate selection, development strategy, and clinical trial design
  • Author and review preclinical study reports, including nonclinical toxicology, DMPK and biomarker sections of regulatory documents
  • Design and interpret PK/PD, efficacy and toxicology studies in collaboration with cross-functional teams
  • Stay current with DMPK scientific literature and emerging technologies to identify potential applications for ongoing programs
  • Help finalize clinical study protocols and reports with focus on DMPK aspects

Requirements

About You:

  • PhD or equivalent in relevant field
  • 7+ years of experience in pharmaceutical/biotechnology setting
  • Strong understanding of DMPK principles and ADME/PK assays in drug development
  • Demonstrated expertise in human PK and dose projections
  • Proven track record as DMPK project representative/leader on multiple project teams
  • Up-to-date knowledge of regulatory guidance related to ADME/PK characterization, drug-drug interaction, and human ADME studies
  • Experience with IND preparation and other regulatory documents
  • Strong communication and collaboration skills with ability to effectively convey ADME/PK risks
  • Experience with covalent modalities, PROTACs and parenteral delivery preferred
  • Demonstrated ability to work effectively in cross-functional team environments

Benefits
  • Foghorn Therapeutics is pleased to provide you and your family with a comprehensive suite of benefits, including:
    • Highly competitive and inclusive medical, dental and vision coverage options
      • BCBS PPO and PPO HSA plans
      • BCBS Dental Plan
      • EyeMed Vision Plan
    • FSA and HSA for medical expenses and dependent care expenses
    • 401(k) Program via Fidelity with the company match
    • Corporate Wellness Program
    • Unlimited Paid Time Off policy
    • Winter shut down
    • 12 weeks of 100% paid parental leave for birthing/primary parent and primary guardian in case of adoption and 3 weeks of 100% paid parental leave for non-birthing/non-primary parent/guardian.
    • Paid Life, LTD and STD insurance coverages, as well as voluntary benefit options
    • Free parking, subsidized commuter passes, or a $100 monthly stipend for walking/biking to work
    • Company lunches on Wednesdays
  • Foghorn Therapeutics is a smoke-free, alcohol-free and drug-free work environment.
  • Foghorn is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Foghorn Therapeutics will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
  • Base salary range for this position: $200,000–$240,000 per year

Top Skills

Adme/Pk
Covalent Modalities
Dmpk
Ind Preparation
Protacs
HQ

Foghorn Therapeutics Cambridge, Massachusetts, USA Office

500 Technology Sq, Suite 700, Cambridge, MA, United States, 02139

Similar Jobs

2 Days Ago
In-Office
Waltham, MA, USA
192K-265K Annually
Senior level
192K-265K Annually
Senior level
Biotech
The Director of DMPK leads drug metabolism and pharmacokinetics strategies, manages a team, collaborates cross-functionally, and ensures compliance in regulatory submissions.
Top Skills: AdmeDmpkPharmacokineticsPharmacologyPk/Pd Modeling
3 Days Ago
In-Office
Cambridge, MA, USA
Senior level
Senior level
Artificial Intelligence • Healthtech • Biotech
The Senior Director/Director of DMPK will lead drug candidate transitions into clinical development, oversee preclinical and clinical pharmacology studies, manage regulatory documents, and collaborate across teams.
Top Skills: Circular Rna TechnologyClinical PharmacologyDmpkInd-Enabling StudiesNanoparticlesPharmacokineticsPharmacology RegulationsPopulation ModelingProgrammatic Medicines
10 Days Ago
In-Office
Waltham, MA, USA
180K-225K Annually
Senior level
180K-225K Annually
Senior level
Healthtech • Biotech
The Director of DMPK will lead drug metabolism and pharmacokinetics functions, executing DMPK strategies across all development stages, managing CROs, and collaborating with cross-functional teams on regulatory submissions.
Top Skills: Winnonlin

What you need to know about the Boston Tech Scene

Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.

Key Facts About Boston Tech

  • Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
  • Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
  • Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
  • Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account